Trading Signals: CEMI Stock Price Prediction and Forecast (Wed. Nov. 26, 2003 - Wed. Jul. 21, 2021)(Chembio Diagnostics Inc)
| CEMI latest price $9.6300 (7.36%) ($8.9700 - $9.7000) on Fri. May. 29, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 11.17% (three month average) | RSI | 41 | Latest Price | $9.6300(7.36%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CEMI declines -1.2% a day on average for past five trading days. | Weekly Trend | CEMI declines -8.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CEMI advance at 0% a week (0% probability) BND(88%) PCY(45%) IBB(43%) BNDX(42%) VCIT(42%) | Factors Impacting CEMI price | CEMI will decline at least -5.585% in a week (0% probabilities). TBT(-30%) URA(-29%) VXX(-23%) XME(-22%) PAVE(-18%) | | | | | Relative Volatility | | | | Market Trend Strength | -5.585% (StdDev 11.17%) | Hourly BBV | 0 () | Intraday Trend | 7.2% | | | |
|
1 - 5 Day Possible Target | $-9.23(-195.85%) | Resistance Level | $11.39 | 5 Day Moving Average | $9.9(-2.73%) | 10 Day Moving Average | $10.6(-9.15%) | 20 Day Moving Average | $11.39(-15.45%) | To recent high | -38% | To recent low | 88.1% | Market Cap | $194m | | | | Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY. |